Angion Biomedica Corp.

NASDAQ: ANGN · Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM

Angion Biomedica Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.62M 50.49M 88.76M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a 874K 723K
Other Long-Term Assets
1.3M 61K 106K
Receivables
n/a 305K 806K
Inventory
n/a 392K 1.44M
Other Current Assets
3.08M 246K 2.49M
Total Current Assets
20.69M 51.43M 91.25M
Property-Plant & Equipment
6.19M 425K 4.44M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
7.49M 1.36M 5.27M
Total Assets
28.18M 52.79M 96.51M
Account Payables
1.04M 2.72M 4.71M
Deferred Revenue
n/a n/a 2.3M
Short-Term Debt
901K 1.06M 952K
Other Current Liabilities
9.58M 2.59M 3.33M
Total Current Liabilities
11.52M 6.37M 11.3M
Long-Term Debt
5.11M 2.65M 3.71M
Other Long-Term Liabilities
22.86M n/a n/a
Total Long-Term Liabilities
27.97M 2.65M 3.71M
Total Liabilities
39.49M 9.02M 15.01M
Total Debt
6.01M 3.71M 4.66M
Common Stock
110K 301K 300K
Retained Earnings
-194.1M -253.94M -215.13M
Comprehensive Income
-175K 86K -103K
Shareholders Equity
-11.31M 43.77M 81.51M
Total Investments
n/a 874K 723K